Subscribe To
ZVRA / Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023
ZVRA News
By GlobeNewsWire
October 31, 2023
Zevra Therapeutics to Report Third Quarter 2023 Results on November 7, 2023, at 8:00 a.m. ET
CELEBRATION, Fla., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics com more_horizontal
By GlobeNewsWire
October 5, 2023
Zevra Therapeutics to Present at the 52nd Child Neurology Society Annual Meeting
Presentation to focus on the arimoclomol program for the treatment of Niemann-Pick Disease type C and related early access programs more_horizontal
By Seeking Alpha
September 5, 2023
Zevra's Rare Find: Unearthing Value In Niche Rare Diseases The Market Overlooks
Zevra's acquisition of Acer Therapeutics adds significant value to its rare disease-focused strategy. Acer's newly launched product, Olpruva, aligns w more_horizontal
By Zacks Investment Research
September 4, 2023
How Much Upside is Left in Zevra Therapeutics (ZVRA)? Wall Street Analysts Think 248.51%
The consensus price target hints at a 248.5% upside potential for Zevra Therapeutics (ZVRA). While empirical research shows that this sought-after met more_horizontal
By Zacks Investment Research
May 15, 2023
Zevra Therapeutics (ZVRA) Reports Q1 Loss, Tops Revenue Estimates
Zevra Therapeutics (ZVRA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to l more_horizontal
By GlobeNewsWire
May 9, 2023
Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023
CELEBRATION, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company, formerly KemPharm, Inc.), a rare more_horizontal
By Seeking Alpha
March 10, 2023
Zevra Therapeutics, Inc. (ZVRA) Q4 2022 Earnings Call Transcript
Zevra Therapeutics, Inc. (NASDAQ:ZVRA ) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Company Participants Nichol Ochsner - Vice President more_horizontal
By GlobeNewsWire
March 6, 2023
Zevra Therapeutics to Present at 35th Annual Roth Conference
CELEBRATION, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (“Zevra” or the “Company” and formerly KemPhar more_horizontal